Table 5.
Distribution of pathogens isolated from urosepsis patients experiencing uroseptic shock
| Total (n = 202) | Urosepsis (n = 118) |
Uroseptic shock(n = 84) | χ2 | P-value | |
|---|---|---|---|---|---|
| Gram-negative bacteria(%) | 186 (92.08) | 112 (94.92) | 74 (88.10) | 3.129 | 0.077 |
| Escherichia coli ESBLs(−) | 74 (36.63) | 64 (54.24%) | 10 (11.90%) | 37.881 | <0.001 |
| Escherichia coli ESBLs(+) | 86 (42.57) | 38 (32.20%) | 48 (57.14%) | 12.483 | <0.001 |
| Klebsiella pneumoniae | 10 (4.95) | 2 (1.69%) | 8 (9.52%) | 4.186 | 0.041 |
| Proteus mirabilis | 8 (3.96) | 4 (3.39%) | 4 (4.76%) | 0.016 | 0.889 |
| Proteus penneri | 4 (1.98) | 2 (1.69%) | 2 (2.38%) | 0.000 | 1.000 |
| Klebsiella aerogenes | 2 (0.99) | 0 (0.00%) | 2 (2.38%) | NA | NA |
| Pseudomonas putida | 2 (0.99) | 2 (1.69%) | 0 (0.00%) | NA | NA |
| Gram-positive bacteria(%) | 4 (1.98) | 2 (1.69%) | 2 (2.38%) | 0.000 | 1.000 |
| Staphylococcus aureus | 4 (1.98) | 2 (1.69%) | 2 (2.38%) | 0.000 | 1.000 |
| Fungus(%) | 12 (5.94) | 4 (3.39%) | 8 (9.52%) | 2.298 | 0.130 |
| Candida albicans | 8 (3.96) | 2 (1.69%) | 6 (7.14%) | 2.531 | 0.112 |
| Candida pseudotropicalis | 2 (0.99) | 0 (0.00%) | 2 (2.38%) | NA | NA |
| Candida glabrata | 2 (0.99) | 2 (1.69%) | 0 (0.00%) | NA | NA |
ESBLs Extended-spectrumβ-lactamases